PUBLISHER: The Business Research Company | PRODUCT CODE: 1825864
PUBLISHER: The Business Research Company | PRODUCT CODE: 1825864
Pharma and biotech CRM software is a specialized solution tailored to aid pharmaceutical and biotech companies in effectively managing customer relationships, data, and interactions. This tool is instrumental in facilitating a seamless and personalized customer experience, empowering organizations to nurture stronger relationships by gaining comprehensive insights into customer interactions.
The primary technology categories for pharma and biotech CRM software encompass artificial intelligence customer relationship management (CRM) and conventional customer relationship management (CRM). AI-driven CRM software for pharma and biotech leverages artificial intelligence and machine learning algorithms to analyze customer data, deliver valuable insights, and automate various tasks. These software solutions are deployed via on-premises or cloud-based models, catering to the needs of both large enterprises and small to medium enterprises (SMEs) operating within the pharmaceutical and biotech industries.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The pharma and biotech CRM software market research report is one of a series of new reports from The Business Research Company that provides pharma and biotech CRM software market statistics, including pharma and biotech CRM software industry global market size, regional shares, competitors with a pharma and biotech CRM software market share, detailed pharma and biotech CRM software market segments, market trends and opportunities, and any further data you may need to thrive in the pharma and biotech CRM software industry. This pharma and biotech CRM software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pharma and biotech crm software market size has grown rapidly in recent years. It will grow from $7.39 billion in 2024 to $8.7 billion in 2025 at a compound annual growth rate (CAGR) of 17.6%. The growth in the historic period can be attributed to a shift towards a customer-centric approach, expanded sales and marketing channels, increased demand for data analytics, an increased need for efficiency and productivity, and a focus on an enhanced customer experience.
The pharma and biotech crm software market size is expected to see rapid growth in the next few years. It will grow to $16.06 billion in 2029 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to emphasizing AI-powered customer insight, growing virtual engagement solutions, integrating with the healthcare ecosystem, ensuring compliance and data security, and expanding mobile and remote access. Major trends in the forecast period include AI-powered customer insights, predictive analytics for healthcare providers, a patient-centric approach, virtual engagement solutions, and an emphasis on digital marketing.
The forecast of 16.6% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. life sciences sector by increasing the cost of Artificial intelligence -powered Customer relationship management platforms and clinical trial management systems sourced from India and Ireland, thereby slowing drug commercialization and elevating sales/marketing expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The escalating demand for personalized medicine is set to drive the growth of the pharma and biotech CRM software market in the foreseeable future. Personalized medicine, a healthcare approach tailored to individual patients based on their genetic makeup, environmental factors, and lifestyle, is gaining traction due to the rising prevalence of chronic diseases and cancer among populations. This growing demand for customized medical solutions necessitates the utilization of pharma and biotech CRM software to efficiently manage patient data, track treatment outcomes, and facilitate personalized healthcare delivery. For instance, as reported by the Personalized Medicine Coalition, 12 new personalized medications were approved in 2022, constituting approximately 34% of all newly approved treatments, signifying a substantial increase compared to previous years. Consequently, the surge in demand for personalized medicine emerges as a key driver propelling the growth of the pharma and biotech CRM software market.
Leading players in the pharma and biotech CRM software market are increasingly integrating artificial intelligence (AI) and machine learning capabilities into their platforms, such as the AI-powered personalized engagement platform, to cater to the evolving needs of the pharmaceutical and biotechnology sectors. AI-powered personalized engagement empowers companies to deliver targeted and relevant messaging to healthcare professionals (HCPs), patients, and other stakeholders. For instance, in October 2023, Salesforce, Inc., a prominent US-based provider of cloud-based software solutions, unveiled its life sciences cloud, designed to streamline patient engagement and clinical operations through data-driven automation and trusted AI. This innovative solution enables pharmaceutical and medical technology organizations to enhance patient engagement, optimize clinical operations, manage commercial lifecycles, and deliver personalized stakeholder experiences throughout the drug and device development journey.
In January 2024, Nomadia, a France-based provider of cloud-based SaaS solutions, acquired Nomadvantage for an undisclosed sum. This strategic acquisition underscores Nomadia's commitment to expanding its portfolio of cloud-based SaaS solutions and bolstering its market presence. Nomadvantage, also based in France, specializes in customer relations management software tailored to the healthcare and pharmaceutical industries, aligning with Nomadia's strategic vision to offer comprehensive solutions to meet the evolving needs of its clients in these sectors.
Major companies operating in the pharma and biotech crm software market are Oracle Corporation, Salesforce.com Inc., IQVIA Holdings Inc., Trueblue Inc., Cirrius Solutions Inc., Veeva Systems Inc., Aurea Software Inc., Indegene Private Limited, Close-Up International Limited, Interactive Medica S.A., StayinFront Inc., Axtria Inc., Navicon Consulting LLC, Aktana Inc., Bpmonline, AKA Enterprise Solutions LLC, Anthill Agency Ltd., Media-Soft Inc., Zephyr Health Inc., Synergistix Inc., Euris S.A., Inova Software Inc., Prolifiq Software Inc., Infonis International Corp., Ivy Software Development Services Pvt. Ltd.
North America was the largest region in the pharma and biotech CRM software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma and biotech crm software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pharma and biotech crm software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The pharma and biotech CRM software market consists of revenues earned by entities through services such as customer relationship management, sales force automation, marketing automation, mobile and remote access, and integration with the healthcare ecosystem. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharma and biotech CRM market also includes sales of lead management software, email marketing software, call centre software, event management software, and training and education software. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pharma And Biotech CRM Software Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on pharma and biotech crm software market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pharma and biotech crm software ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharma and biotech crm software market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.